KoBioLabs, Inc (KOSDAQ: A348150)
Health Care · Biotechnology · KR
₩2,990.00
+12.20% today · -46.1% 1Y
KoBioLabs, Inc (KOSDAQ: A348150) operates in the Biotechnology industry within the Health Care sector. The company is valued at $43.11M.
Over the last twelve months the share price has lost 46.1%, trading between 2.31K and 8.73K.
Tweenvest scores KoBioLabs, Inc across four factors: quality 72/100, value 69/100. Its strongest factor is quality.
A348150 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.11M
- Revenue (TTM)
- $48.69M
- P/E
- —
- EPS
- -247.39
- Dividend yield
- —
- Beta (5Y)
- 0.11
- 52-week high
- ₩8,730.00
- 52-week low
- ₩2,310.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.42M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Adocia SAENXTPA: ADOC | $44.04M | €2.01 | -2.71% |
| Biomolecular Life Holdings, Inc.OTCPK: BIOM | $43.49M | $0.85 | +80.85% |
| NurExone Biologic Inc.TSXV: NRX | $43.29M | CA$0.60 | -6.25% |
| BrightPath Biotherapeutics Co., Ltd.TSE: 4594 | $43.15M | ¥49.00 | -3.92% |
| ABION Inc.KOSDAQ: A203400 | $43.09M | ₩— | — |
| Holy Stone Healthcare Co., Ltd.TPEX: 4194 | $42.80M | NT$9.34 | +29.18% |
| TegoScience Inc.KOSDAQ: A191420 | $42.57M | ₩7,160.00 | -0.42% |
| Psomagen, Inc.KOSDAQ: A950200 | $42.56M | ₩2,980.00 | -4.33% |
Figures last refreshed Oct 4, 2026.